Drug: Motegrity (prucalopride)

Manufacturer: Takeda

Route of Administration: Oral

Site of Care: Outpatient

Approved Indication: treatment of chronic idiopathic constipation in adults

Disease: chronic idiopathic constipation (CIC)

Therapeutic Area: Gastroenterology

Enrollment Form Link: N/A

Phone Number: N/A

Fax Number: N/A

Product Website: motegrity.com